Administering the periostin antibody prolonged cell survival by inhibiting the progression and metastasis of 4T1 cells; therefore, developing the periostin antibody further, including generating a humanized antibody, may provide a new therapeutic agent against breast cancer. This evidence concerns the gene POSTN and breast cancer.